366
Views
32
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study

, , , , , , , , & show all
Pages 674-680 | Received 08 Nov 2013, Accepted 18 Feb 2014, Published online: 20 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Satoshi Kotani, Nobuhiko Fukuba, Kousaku Kawashima, Yoshiyuki Mishima, Hiroki Sonoyama, Eiko Okimoto, Yasumasa Tada, Akihiko Oka, Yuji Tamagawa, Naoki Oshima, Tsuyoshi Mishiro, Hiroshi Tobita, Kotaro Shibagaki, Ichiro Moriyama, Norihisa Ishimura, Yoshinori Kushiyama, Hirofumi Fujishiro & Shunji Ishihara. (2020) Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms. Scandinavian Journal of Gastroenterology 55:5, pages 560-564.
Read now
Jun Kato, Takeichi Yoshida & Sakiko Hiraoka. (2019) Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 15:6, pages 667-677.
Read now

Articles from other publishers (30)

Takayuki Matsumoto, Keita Imai, Yuki Goda, Yuki Fujimitsu, Toshifumi Kajioka, Hideaki Kihara, Yuji Funaki, Shigeru Imaki & Masato Ueno. (2023) Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn’s Disease, Ulcerative Colitis, Patients Survey. Crohn's & Colitis 360 5:4.
Crossref
Natalie Uhlenbusch, Carolin Manthey, Yvonne Nestoriuc, Viola Andresen, Ansgar W. Lohse & Bernd Löwe. (2022) Psychosoziale Unterstützung von Menschen mit Colitis ulcerosa und Reizdarmsyndrom: eine Machbarkeitsstudie zu Bedarf, Fokus und Durchführbarkeit. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie 72:11, pages 481-490.
Crossref
Desislava Dimitrova-Yurukova, Nikola Boyanov, Ventsislav Nakov & Radislav Nakov. (2022) Diagnosis and management of irritable bowel syndrome-like symptoms in ulcerative colitis. Folia Medica 64:5, pages 733-739.
Crossref
Eun Ae Kang. (2022) The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis. Gut and Liver 16:3, pages 487-488.
Crossref
Basel Ebeid, Ragaey A. Eid, Dina Attia, Sahar A. Daoud, Mohammad M. Tawfik & Ali M. Abdel Fattah. (2022) Prevalence of Microscopic Colitis in Diarrhea-predominant Irittable Bowel Syndrome Patients. Journal of Clinical Gastroenterology 56:3, pages e232-e238.
Crossref
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld & T. Wedel. (2021) Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 59:12, pages 1323-1415.
Crossref
Hanna Tufvesson, Julia Dreja, Olle Ekberg, Peter Leander, Sven Månsson & Bodil Ohlsson. (2020) Quantified small bowel motility in patients with ulcerative colitis and gastrointestinal symptoms: a pilot study. Acta Radiologica 62:7, pages 858-866.
Crossref
Keeley M Fairbrass, Sarah J Costantino, David J Gracie & Alexander C Ford. (2020) Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 5:12, pages 1053-1062.
Crossref
Dipesh H Vasant & Alexander C Ford. (2020) Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?. World Journal of Gastroenterology 26:26, pages 3712-3719.
Crossref
Christopher Ma, William J. Sandborn, Geert R. D’Haens, Guangyong Zou, Larry W. Stitt, Siddharth Singh, Ashwin N. Ananthakrishnan, Parambir S. Dulai, Reena Khanna, Vipul Jairath & Brian G. Feagan. (2020) Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis. Clinical Gastroenterology and Hepatology 18:8, pages 1760-1768.e1.
Crossref
Georgios Katinios, Maite Casado-Bedmar, Susanna A Walter, Maria Vicario, Ana M González-Castro, Olga Bednarska, Johan D Söderholm, Henrik Hjortswang & Åsa V Keita. (2020) Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health. Inflammatory Bowel Diseases 26:7, pages 974-984.
Crossref
Muhammet Ozer, Goksel Bengi, Rumeysa Colak, Ozan Cengiz & Hale Akpinar. (2020) Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life. Medicine 99:19, pages e20067.
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Wenting Zhong, Xiaolan Lu, Haitao Shi, Gang Zhao, Yahua Song, Yonghua Wang, Jing Zhang, Yaofeng Jin & Shenhao Wang. (2019) Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis. Journal of Clinical Gastroenterology 53:9, pages 660-672.
Crossref
Daniela Fluxa & Maria T. Abreu. (2019) Therapeutic targets in inflammatory bowel disease. Revista Médica Clínica Las Condes 30:4, pages 315-322.
Crossref
Danilo Carrozzino & Piero Porcelli. (2018) Alexithymia in Gastroenterology and Hepatology: A Systematic Review. Frontiers in Psychology 9.
Crossref
Magne Henriksen, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen & Bjørn Moum. (2018) Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study]. Journal of Crohn's and Colitis 12:4, pages 389-393.
Crossref
Daniela Fluxá, Daniela Simian, Lilian Flores, Patricio Ibáñez, Jaime Lubascher, Carolina Figueroa, Udo Kronberg, Gonzalo Pizarro, Magdalena Castro, Antonio Piottante, María T. Vial & Rodrigo Quera. (2017) Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis. Journal of Digestive Diseases 18:11, pages 634-641.
Crossref
A. Smolinska, A. G. L. Bodelier, J. W. Dallinga, A. A. M. Masclee, D. M. Jonkers, F.‐J. van Schooten & M. J. Pierik. (2017) The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics 45:9, pages 1244-1254.
Crossref
Maisa I. Abdalla, Robert S. Sandler, Michael D. Kappelman, Christopher F. Martin, Wenli Chen, Kristen Anton & Millie D. Long. (2017) Prevalence and Impact of Inflammatory Bowel Disease–Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners. Inflammatory Bowel Diseases 23:2, pages 325-331.
Crossref
Nobuhiko FukubaShunji IshiharaKousaku KawashimaYoshiyuki MishimaNaoki OshimaYoshikazu Kinoshita. (2017) Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission. Intestinal Research 15:4, pages 543.
Crossref
Natalia Pedersen, Dorit Vedel Ankersen, Maria Felding, Henrik Wachmann, Zsuzsanna Végh, Line Molzen, Johan Burisch, Jens Rikardt Andersen & Pia Munkholm. (2017) Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World Journal of Gastroenterology 23:18, pages 3356.
Crossref
Shinichiro Shinzaki, Katsuyoshi Matsuoka, Hideki Iijima, Shinta Mizuno, Satoshi Serada, Minoru Fujimoto, Norimitsu Arai, Noriyuki Koyama, Eiichi Morii, Mamoru Watanabe, Toshifumi Hibi, Takanori Kanai, Tetsuo Takehara & Tetsuji Naka. (2017) Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis. Journal of Crohn's and Colitis 11:1, pages 84-91.
Crossref
Sarah Ballou & Laurie Keefer. (2017) Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases. Clinical and Translational Gastroenterology 8:1, pages e214.
Crossref
D. Lundgren, J. Rutegård, V. Eklöf, R. Palmqvist & P. Karling. (2016) Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls. BMC Gastroenterology 16:1.
Crossref
Toshihiko Tomita, Yu Kato, Mayu Takimoto, Takahisa Yamasaki, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Yoko Yokoyama, Hisatomo Ikehara, Yoshio Ohda, Tadayuki Oshima, Hirokazu Fukui, Shigemi Tanaka, Masayuki Shima, Jiro Watari & Hiroto Miwa. (2016) Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease. Journal of Neurogastroenterology and Motility 22:4, pages 661-669.
Crossref
Yasumasa Tada, Shunji Ishihara, Kousaku Kawashima, Nobuhiko Fukuba, Hiroki Sonoyama, Ryusaku Kusunoki, Akihiko Oka, Yoshiyuki Mishima, Naoki Oshima, Ichiro Moriyama, Takafumi Yuki, Noriyoshi Ishikawa, Asuka Araki, Yuji Harada, Riruke Maruyama & Yoshikazu Kinoshita. (2016) Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis. Journal of Gastroenterology and Hepatology 31:8, pages 1443-1452.
Crossref
Eamonn M. M. Quigley. (2015) Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?. Therapeutic Advances in Gastroenterology 9:2, pages 199-212.
Crossref
Carlos Teruel. (2016) Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 78.
Crossref
Dae Bum Kim, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Hea Jung Sung, Chang Nyol Paik, Woo Chul Chung, Ji-Han Jung & Hyun Joo Choi. (2016) Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis. Gastroenterology Research and Practice 2016, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.